Aandeel 8158 CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen China Regenerative Medicine International Limited

Aandelen

8158

KYG2129W1380

Beurs gesloten - Hong Kong S.E.
Andere beurzen
 10:08:11 08-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,204 HKD +5,70% Intraday-grafiek van China Regenerative Medicine International Limited -20,00% -62,91%
02/04 China Regenerative Medicine International Limited rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023 CI
2023 China Regenerative Medicine International Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
China Regenerative Medicine International Limited Announces CFO Change
China Regenerative Medicine International Limited Announces Executive Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2021
China Regenerative Medicine International Limited Announces Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021
China Regenerative Medicine International Limited Announces Board Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
China Regenerative Medicine International Limited Announces Executive Changes
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
China Regenerative Medicine International Limited Announces the Cessation of Lee Pak Chung as Chief Financial Officer
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2020
China Regenerative Medicine International Limited Enters into Non-Legally Binding Memorandum of Understanding with Jinxin Holdings Co, Ltd
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 8158
  4. Nieuws China Regenerative Medicine International Limited
  5. Andere talen